Aptamer Group (LSE:APTA) Pre-Tax Income : £-7.23 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Aptamer Group's pretax income for the six months ended in Dec. 2023 was £-1.90 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was £-7.23 Mil. Aptamer Group's pretax margin was -638.59%.

During the past 4 years, Aptamer Group's highest Pretax Margin was -60.28%. The lowest was -698.84%. And the median was -87.71%.

Aptamer Group Pre-Tax Income Historical Data

The historical data trend for Aptamer Group's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Pre-Tax Income Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Pre-Tax Income

-0.60

-0.94

-2.64

-8.30

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial			-1.18	-1.46	-2.97	-5.33	-1.90

Competitive Comparison of Aptamer Group's Pre-Tax Income

For the Biotechnology subindustry, Aptamer Group's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptamer Group's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Pre-Tax Income falls into.

Aptamer Group Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Aptamer Group's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-8.157	+	0	+	-0.132	+	0	+	-0.0090000000000003
	=	-8.30

Aptamer Group's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.872	+	0	+	-0.042	+	0.011	+	2.2204460492503E-16
	=	-1.90

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-7.23 Mil.

Aptamer Group (LSE:APTA) Pre-Tax Income Explanation

Aptamer Group's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.903	/	0.298
	=	-638.59%

During the past 4 years, Aptamer Group's highest Pretax Margin was -60.28%. The lowest was -698.84%. And the median was -87.71%.

Aptamer Group Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptamer Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

P0J:Germany

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group Headlines

No Headlines